Genentech’s earnings soared 89%in the second quarter...

Genentech’s earnings soared 89%in the second quarter to $5.3 million. The South San Francisco biotechnology company said its sales of Protropin brand of pharmaceuticals increased 111% from the year-ago period. Latest quarter income included an extraordinary item related to a tax-loss carryforward.